12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Lonza sales and marketing update

Lonza launched its microbial-based platform to produce plasmid DNA vaccines and therapeutics. Lonza said the platform...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >